Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 26, 2018
Haemophilia care in Latin America: Assessment and perspectivesApsara Boadas, Margareth C Ozelo, Maria Solano, et al.
Journal of the American Heart Association|February 4, 2020
Angiogenesis-Related Genes in Endothelial Progenitor Cells May Be Involved in Sickle Cell StrokeMirta T Ito, Sueli M da Silva Costa, Letícia C Baptista, et al.
Annals of Nuclear Medicine|January 3, 2021
Knee radiosynovectomy with 153Sm-hydroxyapatite compared to 90Y-hydroxyapatite: initial results of a prospective trialAllan O Santos, Janaina B S Ricciardi, Rodrigo Pagnano, et al.
Science Translational Medicine|May 8, 2024
The translational gap for gene therapies in low- and middle-income countriesKevin W Doxzen, Jennifer E Adair, Yris Maria Fonseca Bazzo, et al.
Blood Advances|February 11, 2021
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand diseaseNathan T Connell, Veronica H Flood, Romina Brignardello-Petersen, et al.
Blood Advances|October 21, 2021
Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literatureRomina Brignardello-Petersen, Abdallah El Alayli, Nedaa Husainat, et al.
Research and Practice in Thrombosis and Haemostasis|May 1, 2026
Durability of efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A: final phase 3 GENEr8-1 trial resultsAndrew D Leavitt, Johnny Mahlangu, Priyanka Raheja, et al.
British Journal of Haematology|September 12, 2014
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG studyJerry S Powell, Shashikant Apte, Hervé Chambost, et al.
The New England Journal of Medicine|March 16, 2022
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia AMargareth C Ozelo, Johnny Mahlangu, K John Pasi, et al.
Pageof 7